Completed PHASE1 INTERVENTIONAL 4-arm NCT01871844

ITF2984 Repeated Doses Study in Healthy Volunteers (MAD)

A Within Group, Randomised, Phase I, Repeated Doses, Placebo and Octreotide Controlled Study in Healthy Volunteers to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Incremental Doses of ITF2984

Sponsor: Italfarmaco

Conditions Healthy Male Volunteers

Interventions ITF2984 (500, 1000, 2000 mcg bid for 7 days) Placebo octreotide 50 mcg tid

Updated 5 times since 2017 Last updated: Jun 4, 2013 Started: Jan 31, 2012 Primary completion: Sep 30, 2012 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Male Volunteers and is currently completed. Italfarmaco leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Italfarmaco

Data source: Italfarmaco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ruddington, United Kingdom
• Verona, Italy